This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
申请公布号
EP2445526(B1)
申请公布日期
2016.05.11
申请号
EP20100724879
申请日期
2010.06.24
申请人
GLAXOSMITHKLINE BIOLOGICALS S.A.;ID BIOMEDICAL CORPORATION OF QUEBEC
发明人
BAUDOUX, GUY JEAN MARIE FERNAND PIERRE;BLAIS, NORMAND;CYR, SONYA L;RHEAULT, PATRICK;RUELLE, JEAN LOUIS
